Personalis Inc. (PSNL)
NASDAQ
Closed
Aug 26, 2026
Day's Range
16.8552 wk Range
4.65Profile - PSNL - Personalis Inc.
Profile
Mic Code
XNMS
Sector
Healthcare
Industry
Diagnostics & Research
Employees
259
Personalis Inc. is a biotechnology company specializing in advanced genomics services for precision medicine and oncology. Its primary function is to analyze complex genetic information for clinical and academic research, aiding in the development of targeted therapeutics and personalized treatments. The company's offerings include a comprehensive platform that integrates genomic data generation with advanced bioinformatics, focusing particularly on cancer genomics and the immune response. Personalis Inc. collaborates with leading research institutions, biopharmaceutical companies, and healthcare providers to enhance the understanding of disease mechanisms and improve therapeutic strategies. Headquartered in Menlo Park, California, Personalis plays a significant role in the biotech industry by contributing to innovations in personalized healthcare, precision diagnostics, and genomics-driven therapeutic development.
Profile Details
Type
Common Stock
Ceo
Mr. Christopher M. Hall
Address
6600 Dumbarton Circle
City
Fremont
State
CA
Zip
94555
Country
United States
Phone
650 752 1300
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
